Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Steroid Withdrawal in Pediatric Kidney Transplant Recipients

ClinicalTrials.gov ID: NCT00023244

Public ClinicalTrials.gov record NCT00023244. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 9:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind Randomized Trial of Steroid Withdrawal in Sirolimus- and Cyclosporine-Treated Primary Transplant Recipients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to examine the effects of withdrawing steroids on graft rejection and kidney functions in kidney transplant recipients between the ages of 0 and 20 years (prior to their 21st birthday). Graft survival has improved in recent years in children with kidney transplants. One bad side effect of steroid maintenance therapy has been growth retardation. Doctors believe steroids might be safely withdrawn in patients that are receiving other maintenance therapies. If steroids are removed, children might catch up in their growth and also might have fewer side effects of other kinds. This study evaluates whether steroid therapy can be withdrawn in a way that does not increase graft rejection.

Study identification

NCT ID
NCT00023244
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Enrollment
274 participants

Conditions and interventions

Eligibility (public fields only)

Age range
1 Day to 20 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2001 (Type not available)
Primary completion
Jun 2005 (Actual)
Completion
Jun 2005 (Actual)
Last update posted
Oct 21, 2016

2001 – 2005

United States locations

U.S. sites
18
U.S. states
16
U.S. cities
17
Facility City State ZIP Site status
University of Alabama Birmingham Alabama 35233 —
UCSD Medical Center San Diego California 92103 —
Denver Children's Hospital Aurora Colorado 80045 —
University of Florida Health Science Center Jacksonville Florida 32209 —
Emory Children's Center Atlanta Georgia 30322 —
Tulane University Medical Center New Orleans Louisiana 70112 —
University of Maryland Medical Center Baltimore Maryland 21201 —
Children's Hospital of Boston Boston Massachusetts 02115 —
University of New Mexico Health Science Center Albuquerque New Mexico 87131 —
The Children's Hospital of Buffalo Buffalo New York 14222 —
Westchester Medical Center Valhalla New York 10595 —
Rainbow Babies and Childrens Hospital Cleveland Ohio 44106 —
University Hospitals of Cleveland Cleveland Ohio 44106 —
Penn State College of Medicine Hershey Pennsylvania 17033 —
LeBonheur Children's Medical Center Memphis Tennessee 38103 —
Christopher Goldsbury Center San Antonio Texas 78207 —
Children's Hospital and Regional Medical Center Seattle Washington 98105 —
University of Wisconsin Madison Wisconsin 53705 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00023244, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 21, 2016 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00023244 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →